320 related articles for article (PubMed ID: 21372715)
21. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
[TBL] [Abstract][Full Text] [Related]
22. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.
Stevens WW; Jerschow E; Baptist AP; Borish L; Bosso JV; Buchheit KM; Cahill KN; Campo P; Cho SH; Keswani A; Levy JM; Nanda A; Laidlaw TM; White AA
J Allergy Clin Immunol; 2021 Mar; 147(3):827-844. PubMed ID: 33307116
[TBL] [Abstract][Full Text] [Related]
23. Current complications and treatment of aspirin-exacerbated respiratory disease.
Cook KA; Stevenson DD
Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
[TBL] [Abstract][Full Text] [Related]
24. Cytokine expression in peripheral blood lymphocytes before and after aspirin desensitization in aspirin-exacerbated respiratory disease.
Shome GP; Tarbox J; Shearer M; Kennedy R
Allergy Asthma Proc; 2007; 28(6):706-10. PubMed ID: 18201436
[TBL] [Abstract][Full Text] [Related]
25. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
26. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis.
Sousa AR; Parikh A; Scadding G; Corrigan CJ; Lee TH
N Engl J Med; 2002 Nov; 347(19):1493-9. PubMed ID: 12421891
[TBL] [Abstract][Full Text] [Related]
27. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
28. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
Macy E; Bernstein JA; Castells MC; Gawchik SM; Lee TH; Settipane RA; Simon RA; Wald J; Woessner KM;
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886
[TBL] [Abstract][Full Text] [Related]
29. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
30. Aspirin intolerance: does desensitization alter the course of the disease?
Klimek L; Pfaar O
Immunol Allergy Clin North Am; 2009 Nov; 29(4):669-75. PubMed ID: 19879442
[TBL] [Abstract][Full Text] [Related]
31. Pathophysiology of chronic rhinosinusitis with nasal polyp.
Hsu J; Peters AT
Am J Rhinol Allergy; 2011; 25(5):285-90. PubMed ID: 22186239
[TBL] [Abstract][Full Text] [Related]
32. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
Mullol J; Picado C
Immunol Allergy Clin North Am; 2013 May; 33(2):163-76. PubMed ID: 23639706
[TBL] [Abstract][Full Text] [Related]
33. [Chronic rhinosinusitis in morbus widal: clinical aspects and therapeutic options].
Jung H
Praxis (Bern 1994); 2009 Nov; 98(23):1361-5; quiz 1363, 1365. PubMed ID: 19918728
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulatory treatments for aspirin exacerbated respiratory disease.
Moebus RG; Han JK
Am J Rhinol Allergy; 2012; 26(2):134-40. PubMed ID: 22487291
[TBL] [Abstract][Full Text] [Related]
35. The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps.
Ba L; Zhang N; Meng J; Zhang J; Lin P; Zhou P; Liu S; Bachert C
Allergy; 2011 Oct; 66(10):1296-303. PubMed ID: 21575009
[TBL] [Abstract][Full Text] [Related]
36. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements.
Pfaar O; Klimek L
Curr Opin Allergy Clin Immunol; 2006 Jun; 6(3):161-6. PubMed ID: 16670507
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis.
Pérez-Novo CA; Watelet JB; Claeys C; Van Cauwenberge P; Bachert C
J Allergy Clin Immunol; 2005 Jun; 115(6):1189-96. PubMed ID: 15940133
[TBL] [Abstract][Full Text] [Related]
38. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).
Simon RA; Dazy KM; Waldram JD
Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486
[TBL] [Abstract][Full Text] [Related]
39. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro.
Sachse F; Becker K; von Eiff C; Metze D; Rudack C
Allergy; 2010 Nov; 65(11):1430-7. PubMed ID: 20456313
[TBL] [Abstract][Full Text] [Related]
40. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
